CF PharmTech buys back 11,500 H-shares, bringing treasury stock to 719,000

Bulletin Express05-12

CF PharmTech, Inc. disclosed that it repurchased 11,500 H-shares on 12 May 2026, all of which are being held as treasury shares.

• Size and price: The shares were bought on the Hong Kong Stock Exchange at prices ranging from HK$21.62 to HK$21.80, with a volume-weighted average of HK$21.71. Total consideration was approximately HK$0.25 million.

• Capital structure after the transaction: – Issued shares (excluding treasury shares) decreased to 301.50 million. – Treasury shares rose to 719,000. – Total issued shares remained unchanged at 302.22 million. – The buy-back represented 0.0038 % of the company’s issued share capital (excluding treasury shares) prior to the transaction.

• Repurchase mandate utilisation: – The current mandate, approved on 16 December 2025, allows the company to repurchase up to 30.22 million shares. – Cumulative repurchases under this mandate now stand at 719,000 shares, or 0.24 % of the issued shares outstanding on the mandate date.

• Moratorium: Under Hong Kong listing rules, the company may not issue new shares or dispose of treasury shares until 11 June 2026.

The repurchase was authorised by the board and conducted in full compliance with Main Board Rule 10.06 and other applicable regulations, according to Executive Director and Joint Company Secretary Zhu Yuyu.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1196947797?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-12 19:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1196947797","market":"hk","top_or_hot":-1,"title":"CF PharmTech buys back 11,500 H-shares, bringing treasury stock to 719,000","media":"Bulletin Express","content":"<p>CF PharmTech, Inc. disclosed that it repurchased 11,500 H-shares on 12 May 2026, all of which are being held as treasury shares.</p>\n<p>• Size and price: The shares were bought on the Hong Kong Stock Exchange at prices ranging from HK$21.62 to HK$21.80, with a volume-weighted average of HK$21.71. Total consideration was approximately HK$0.25 million.</p>\n<p>• Capital structure after the transaction:  \n  – Issued shares (excluding treasury shares) decreased to 301.50 million.  \n  – Treasury shares rose to 719,000.  \n  – Total issued shares remained unchanged at 302.22 million.  \n  – The buy-back represented 0.0038 % of the company’s issued share capital (excluding treasury shares) prior to the transaction.</p>\n<p>• Repurchase mandate utilisation:  \n  – The current mandate, approved on 16 December 2025, allows the company to repurchase up to 30.22 million shares.  \n  – Cumulative repurchases under this mandate now stand at 719,000 shares, or 0.24 % of the issued shares outstanding on the mandate date.</p>\n<p>• Moratorium: Under Hong Kong listing rules, the company may not issue new shares or dispose of treasury shares until 11 June 2026.</p>\n<p>The repurchase was authorised by the board and conducted in full compliance with Main Board Rule 10.06 and other applicable regulations, according to Executive Director and Joint Company Secretary Zhu Yuyu.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CF PharmTech buys back 11,500 H-shares, bringing treasury stock to 719,000</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCF PharmTech buys back 11,500 H-shares, bringing treasury stock to 719,000\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-05-12 19:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>CF PharmTech, Inc. disclosed that it repurchased 11,500 H-shares on 12 May 2026, all of which are being held as treasury shares.</p>\n<p>• Size and price: The shares were bought on the Hong Kong Stock Exchange at prices ranging from HK$21.62 to HK$21.80, with a volume-weighted average of HK$21.71. Total consideration was approximately HK$0.25 million.</p>\n<p>• Capital structure after the transaction:  \n  – Issued shares (excluding treasury shares) decreased to 301.50 million.  \n  – Treasury shares rose to 719,000.  \n  – Total issued shares remained unchanged at 302.22 million.  \n  – The buy-back represented 0.0038 % of the company’s issued share capital (excluding treasury shares) prior to the transaction.</p>\n<p>• Repurchase mandate utilisation:  \n  – The current mandate, approved on 16 December 2025, allows the company to repurchase up to 30.22 million shares.  \n  – Cumulative repurchases under this mandate now stand at 719,000 shares, or 0.24 % of the issued shares outstanding on the mandate date.</p>\n<p>• Moratorium: Under Hong Kong listing rules, the company may not issue new shares or dispose of treasury shares until 11 June 2026.</p>\n<p>The repurchase was authorised by the board and conducted in full compliance with Main Board Rule 10.06 and other applicable regulations, according to Executive Director and Joint Company Secretary Zhu Yuyu.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02652","symbol_name":"长风药业","start_time":0,"source_url":"","article_id":"1196947797","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1196947797","pubTimestamp":1778583817,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"CF PharmTech, Inc. disclosed that it repurchased 11,500 H-shares on 12 May 2026, all of which are being held as treasury shares. • Size and price: The shares were bought on the Hong Kong Stock...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02652":"长风药业"},"translate_title":"CF PharmTech回购11,500股H股，库存股达到719,000股","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02652":1},"content_text":"CF PharmTech, Inc. disclosed that it repurchased 11,500 H-shares on 12 May 2026, all of which are being held as treasury shares.\n• Size and price: The shares were bought on the Hong Kong Stock Exchange at prices ranging from HK$21.62 to HK$21.80, with a volume-weighted average of HK$21.71. Total consideration was approximately HK$0.25 million.\n• Capital structure after the transaction:  \n  – Issued shares (excluding treasury shares) decreased to 301.50 million.  \n  – Treasury shares rose to 719,000.  \n  – Total issued shares remained unchanged at 302.22 million.  \n  – The buy-back represented 0.0038 % of the company’s issued share capital (excluding treasury shares) prior to the transaction.\n• Repurchase mandate utilisation:  \n  – The current mandate, approved on 16 December 2025, allows the company to repurchase up to 30.22 million shares.  \n  – Cumulative repurchases under this mandate now stand at 719,000 shares, or 0.24 % of the issued shares outstanding on the mandate date.\n• Moratorium: Under Hong Kong listing rules, the company may not issue new shares or dispose of treasury shares until 11 June 2026.\nThe repurchase was authorised by the board and conducted in full compliance with Main Board Rule 10.06 and other applicable regulations, according to Executive Director and Joint Company Secretary Zhu Yuyu.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1196947797","isCrawlerRequest":true}